We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+20.32%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$95.4M
Cap. Flow
+$54.8M
Cap. Flow %
17.62%
Top 10 Hldgs %
42.33%
Holding
114
New
30
Increased
24
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.25M
2
BHVN icon
Biohaven
BHVN
+$1.67M
3
LLY icon
Eli Lilly
LLY
+$1.25M
4
MU icon
Micron Technology
MU
+$1.15M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$814K

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$5.45M
2
UBER icon
Uber
UBER
+$5.13M
3
BABA icon
Alibaba
BABA
+$4.44M
4
AZN icon
AstraZeneca
AZN
+$3.2M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$3.03M

Sector Composition

Rank Sector Weight
1 Healthcare 24.79%
2 Technology 21.41%
3 Communication Services 6.89%
4 Financials 3.39%
5 Consumer Discretionary 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MU icon
1
Micron Technology
MU
$835B
$34.3M 11.04%
205,250
+9,000
+5% +$1.15M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.11T
$13.9M 4.46%
57,000
– –
ARGX icon
3
argenx
ARGX
$55.2B
$10.1M 3.24%
13,650
– –
GDX icon
4
VanEck Gold Miners ETF
GDX
$22.5B
$8.75M 2.81%
114,500
+12,000
+12% +$723K
ORCL icon
5
Oracle
ORCL
$339B
$8.16M 2.62%
29,000
-4,500
-13% -$1.15M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$40.4B
$7.43M 2.39%
367,700
+185,200
+101% +$3.25M
IAU icon
7
iShares Gold Trust
IAU
$62.8B
$7.28M 2.34%
100,000
– –
IONS icon
8
Ionis Pharmaceuticals
IONS
$8.93B
$7.09M 2.28%
108,413
+16,663
+18% +$814K
MU icon
9
PUT
Micron Technology
MU
$835B
$6.94M 2.23%
41,500
-1,000
-2% -$128K
AMZN icon
10
Amazon
AMZN
$2.44T
$6.42M 2.06%
29,250
-6,600
-18% -$1.49M
LLY icon
11
Eli Lilly
LLY
$1.08T
$6.33M 2.03%
8,300
+1,675
+25% +$1.25M
BAC icon
12
Bank of America
BAC
$429B
$6.17M 1.98%
119,500
– –
REGN icon
13
Regeneron Pharmaceuticals
REGN
$72.9B
$5.62M 1.81%
10,000
+600
+6% +$339K
GLD icon
14
SPDR Gold Trust
GLD
$131B
$5.33M 1.71%
15,000
– –
AMD icon
15
Advanced Micro Devices
AMD
$700B
$5.26M 1.69%
32,500
-2,500
-7% -$403K
BIDU icon
16
Baidu
BIDU
$35.7B
$5.2M 1.67%
39,500
-13,000
-25% -$1.29M
NAMS icon
17
NewAmsterdam Pharma
NAMS
$3.26B
$4.98M 1.6%
175,250
+2,750
+2% +$65.9K
EVO icon
18
Evotec
EVO
$686M
$4.35M 1.4%
1,198,993
+84,500
+8% +$321K
SLV icon
19
iShares Silver Trust
SLV
$27.7B
$4.24M 1.36%
100,000
– –
CSCO icon
20
Cisco
CSCO
$443B
$4.11M 1.32%
60,000
+2,500
+4% +$170K
C icon
21
Citigroup
C
$213B
$3.65M 1.17%
36,000
– –
INCY icon
22
Incyte
INCY
$25.4B
$3.52M 1.13%
41,500
– –
LFCR icon
23
Lifecore Biomedical
LFCR
$162M
$3.33M 1.07%
452,000
-10,987
-2% -$83.1K
AMGN icon
24
Amgen
AMGN
$209B
$3.25M 1.04%
11,500
+1,000
+10% +$290K
ZLAB icon
25
Zai Lab
ZLAB
$2.07B
$3.12M 1%
92,000
+1,000
+1% +$34.4K
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, DCF Advisers held 114 positions worth $311M, up 44% from $216M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

DCF Advisers deployed $54.8M of net new capital in Q3 2025, opening 30 new positions and adding to 24 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.49M trimmed.

  • DCF Advisers added most to Teva Pharmaceuticals in Q3 2025, an estimated $3.25M increase.
  • DCF Advisers's biggest Q3 2025 reduction was Amazon, cutting an estimated $1.49M.
  • DCF Advisers fully exited Energy Transfer Partners in Q3 2025, selling an estimated $5.45M.
  • DCF Advisers's ten largest holdings make up 42% of its $311M portfolio in Q3 2025.
  • DCF Advisers opened 30 new positions and closed 19 in Q3 2025.
  • DCF Advisers's portfolio value rose 44% quarter-over-quarter to $311M.

Based on DCF Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.